Traditional classification systems of breast cancer are based on various biological characteristics, including histological grade, tumor size, lymph node involvement, estrogen receptors (ER), progesterone receptors (PGR), and human epidermal growth factor receptor 2 (HER2) status. This evidence concerns the gene ERBB2 and breast carcinoma.